Otsuka Holdings Co., Ltd. – Unsponsored ADR (OTCMKTS:OTSKY) Short Interest Down 50.0% in May

Otsuka Holdings Co., Ltd. – Unsponsored ADR (OTCMKTS:OTSKY – Get Free Report) was the target of a large decrease in short interest in the month of May. As of May 29th, there was short interest totaling 39,619 shares, a decrease of 50.0% from the May 14th total of 79,267 shares. Currently, 0.0% of the shares of the stock are sold short. Based on an average trading volume of 84,492 shares, the short-interest ratio is currently 0.5 days.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on OTSKY shares. Zacks Research raised Otsuka from a “strong sell” rating to a “hold” rating in a research note on Tuesday, March 31st. The Goldman Sachs Group lowered shares of Otsuka from a “strong-buy” rating to a “strong sell” rating in a report on Friday, February 27th. One analyst has rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of “Hold”.

Get Otsuka alerts:

Check Out Our Latest Report on OTSKY

Otsuka Trading Down 0.5%

Shares of OTSKY stock traded down $0.15 on Monday, hitting $31.91. 48,680 shares of the company’s stock traded hands, compared to its average volume of 38,556. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.67 and a current ratio of 2.17. Otsuka has a one year low of $21.68 and a one year high of $37.52. The company’s fifty day simple moving average is $34.68 and its 200 day simple moving average is $32.31. The stock has a market capitalization of $34.28 billion and a price-to-earnings ratio of 13.46.

Otsuka (OTCMKTS:OTSKY – Get Free Report) last released its quarterly earnings data on Tuesday, April 28th. The company reported $0.59 EPS for the quarter, topping the consensus estimate of $0.43 by $0.16. The firm had revenue of $3.96 billion for the quarter, compared to the consensus estimate of $3.78 billion. Otsuka had a return on equity of 12.33% and a net margin of 15.01%.Otsuka has set its FY 2026 guidance at 1.610-1.610 EPS. Equities analysts forecast that Otsuka will post 1.98 EPS for the current year.

Otsuka Company Profile

(Get Free Report)

Otsuka Pharmaceutical Co, Ltd., trading in the U.S. under the ticker OTCMKTS:OTSKY, is a global healthcare company headquartered in Tokyo, Japan. The firm’s core activities span the development, manufacturing and marketing of prescription pharmaceuticals, consumer healthcare products and nutraceuticals. Otsuka focuses its research on areas such as neuroscience, cardiovascular and renal therapies, and oncology, aiming to bring innovative treatments to patients worldwide.

Founded in 1964 by Busaburo Otsuka as a subsidiary of the Otsuka Group, the company has grown into a diversified healthcare enterprise over more than five decades.

See Also

• Five stocks we like better than Otsuka
• These 5 Companies Just Made a Massive Bet on Themselves
• 5 Stocks Built to Thrive in a Higher-for-Longer Economy
• RH’s Strong Q1 Still Leaves Investors With One Big Question
• Iran Ceasefire or Not, These 3 Companies Could Win

Receive News & Ratings for Otsuka Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Otsuka and related companies with MarketBeat.com's FREE daily email newsletter.